126 related articles for article (PubMed ID: 3608889)
1. Heterogeneity of muscarinic cholinergic receptors in the developing human fetal brain: regional distribution and characterization.
Gremo F; Palomba M; Marchisio AM; Marcello C; Mulas ML; Torelli S
Early Hum Dev; 1987 May; 15(3):165-77. PubMed ID: 3608889
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
Tonnaer JA; Ernste BH; Wester J; Kelder K
J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
[TBL] [Abstract][Full Text] [Related]
3. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
4. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic cholinergic receptors in human infant forebrain: [3H]quinuclidinyl benzilate binding in homogenates and quantitative autoradiography in sections.
Johnston MV; Silverstein FS; Reindel FO; Penney JB; Young AB
Brain Res; 1985 Apr; 351(2):195-203. PubMed ID: 3995346
[TBL] [Abstract][Full Text] [Related]
6. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
7. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
8. A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.
Watson M; Yamamura HI; Roeske WR
Life Sci; 1983 Jun; 32(26):3001-11. PubMed ID: 6688111
[TBL] [Abstract][Full Text] [Related]
9. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
10. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
Cortés R; Probst A; Tobler HJ; Palacios JM
Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
[TBL] [Abstract][Full Text] [Related]
12. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
13. Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain.
Piggott M; Owens J; O'Brien J; Paling S; Wyper D; Fenwick J; Johnson M; Perry R; Perry E
J Chem Neuroanat; 2002 Sep; 24(3):211-23. PubMed ID: 12297267
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic muscarinic receptors in human fetal brain: ontogeny of [3H]quinuclidinyl benzilate binding sites in corpus striatum, brainstem, and cerebellum.
Ravikumar BV; Sastry PS
J Neurochem; 1985 Dec; 45(6):1948-50. PubMed ID: 4056800
[TBL] [Abstract][Full Text] [Related]
15. [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.
Wang JX; Roeske WR; Gulya K; Wang W; Yamamura HI
Life Sci; 1987 Oct; 41(14):1751-60. PubMed ID: 3657382
[TBL] [Abstract][Full Text] [Related]
16. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS
Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989
[TBL] [Abstract][Full Text] [Related]
17. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
18. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
el-Fakahany EE; Ramkumar V; Lai WS
J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
[TBL] [Abstract][Full Text] [Related]
19. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
20. Evidence for multiple muscarinic receptor subtypes in human brain.
Garvey JM; Rossor M; Iversen LL
J Neurochem; 1984 Aug; 43(2):299-302. PubMed ID: 6547475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
